Surface anesthetic effect and subjective compatibility of 2% carteolol and 0.6% metipranolol in eye-healthy people.
In a placebo-controlled, randomized, prospective, parallel, double-masked trail we study corneal sensitivity before and after application of 2% carteolol (20 eyes) and 0.6% metipranolol (20 eyes). 2% carteolol does not decrease corneal sensitivity (no significant difference to the placebo group). 0.6% metipranolol leads to a decrease of corneal sensitivity up to 14 mg/S (median), lasting up to 15 minutes. The local anesthetic effect is an important parameter for the subjective compatibility.